Latest Governance And Risk News

AVITA Medical has lodged a new $200 million shelf registration with the SEC, renewing its capacity to issue various securities in the US market. While no immediate capital raising is planned, this move preserves the company’s financial agility for future growth opportunities.

Emu NL has announced a pro-rata non-renounceable rights issue aiming to raise approximately $3.67 million, offering new shares with free attaching options to eligible shareholders. The capital raise will primarily fund exploration activities at its Queensland projects and strengthen working capital.

Austal Limited has addressed ASX concerns over its half-year financial report, confirming compliance with accounting standards despite a qualified audit opinion linked to US Department of Defense contractual relief revenue.

ClearVue Technologies reported a 9% reduced half-year loss of $5.25 million, while pushing forward with significant advancements in its solar glass technology and expanding global licensing partnerships.

Future Generation Australia Limited reported robust financial results for 2025, with a 14.1% investment portfolio gain and a raised fully franked dividend, while continuing its commitment to social impact funding for vulnerable children.

Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.

Volt Group Limited reported an 8% revenue decline and a 66% drop in profit for 2025, while advancing its growth strategy through a major acquisition and share consolidation.

Iress Limited reported a 7.4% revenue decline to $556.3 million for FY25 but achieved a 21.5% rise in profit before tax, declaring a fully franked final dividend of 13 cents per share. The company sharpened its focus on core Wealth and Trading software businesses while advancing sustainability and AI innovation.

Viva Energy Group Limited reported a significant net loss for 2025, driven by retail asset impairments, yet underlying profits and strategic investments signal resilience and a clear path forward.

WAM Strategic Value Limited has reported a robust half-year performance, with net profit soaring 158.6% and an increased fully franked interim dividend. The company’s investment portfolio outperformed the market, underpinning strong shareholder returns.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Bell Financial Group delivered a robust 17.1% rise in net profit after tax to $36 million for 2025, driven by strong growth in its Platforms division and a rebound in market activity. The company declared a fully franked final dividend of 6.5 cents per share, signalling confidence as it prepares to launch a new wealth management platform in 2026.